Detailed Clinical Phenotype and Molecular Genetic Findings in <i>CLN3</i>-Associated Isolated Retinal Degeneration

  • Cristy A. Ku
    Casey Eye Institute, Oregon Health & Science University, Portland
  • Sarah Hull
    University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England
  • Gavin Arno
    University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England
  • Ajoy Vincent
    Department of Ophthalmology and Vision Sciences, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
  • Keren Carss
    National Health Service Blood and Transplant Centre, Department of Haematology, University of Cambridge, Cambridge, England6National Institute for Health Research BioResource: Rare Diseases, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, England
  • Robert Kayton
    Pathology Department, Oregon Health & Science University, Portland
  • Douglas Weeks
    Pathology Department, Oregon Health & Science University, Portland
  • Glenn W. Anderson
    Histopathology Department, Great Ormond Street Hospital for Children, London, England
  • Ryan Geraets
    Sanford Children’s Health Research Center, Sanford Research, Sioux Falls, South Dakota
  • Camille Parker
    Sanford Children’s Health Research Center, Sanford Research, Sioux Falls, South Dakota
  • David A. Pearce
    Sanford Children’s Health Research Center, Sanford Research, Sioux Falls, South Dakota10Department of Pediatrics, Sanford School of Medicine, University of South Dakota, Sioux Falls
  • Michel Michaelides
    University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England
  • Robert E. MacLaren
    Moorfields Eye Hospital, London, England11Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, University of Oxford, Oxford, England12Oxford University Hospitals National Health Service Foundation Trust, Oxford, England
  • Anthony G. Robson
    University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England
  • Graham E. Holder
    University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England
  • Elise Heon
    Department of Ophthalmology and Vision Sciences, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
  • F. Lucy Raymond
    National Health Service Blood and Transplant Centre, Department of Haematology, University of Cambridge, Cambridge, England6National Institute for Health Research BioResource: Rare Diseases, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, England13Cambridge Institute for Medical Research, Department of Medical Genetics, University of Cambridge, Cambridge, England
  • Anthony T. Moore
    University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England14Department of Ophthalmology, University of California, San Francisco Medical School, San Francisco
  • Andrew R. Webster
    University College London Institute of Ophthalmology, London, England3Moorfields Eye Hospital, London, England
  • Mark E. Pennesi
    Casey Eye Institute, Oregon Health & Science University, Portland

収録刊行物

  • JAMA Ophthalmology

    JAMA Ophthalmology 135 (7), 749-, 2017-07-01

    American Medical Association (AMA)

被引用文献 (2)*注記

もっと見る

問題の指摘

ページトップへ